HD LifeSciences Launches New Implant Footprints at State of Spine Surgery Meeting


HD Lifesciences launched 3 new implant footprints at the State of Spine Surgery Meeting in Aruba last month, including a Hyperlordotic TLIF, Hyperlordotic ALIF, and Curved TLIF. This expands the Soft Titanium® portfolio to 14 product lines and accommodates a variety of surgeon preferences and patient anatomies for PLIF, TLIF, ALIF, or ACDF procedures.

HD Lifesciences’ Soft Titanium® structural lattice has been implanted over 1,650 times since its introduction in summer of 2017. Over 500 have been Hive™ TLIFs with the insert-and-rotate technique. Over the next 24 months, HD plans to publish multiple clinical and experimental studies to demonstrate the biological and biomechanical advantages of Soft Titanium®.

About HD LifeSciences

HD Lifesciences is transforming orthopedic care with our Hive™ Soft Titanium® technology. The Hive™ lattice design provides ideal elastic modulus, diagnostic imaging, and osteogenic properties. Founded with a mission to improve surgical methods and devices, HD LifeSciences brings together science and engineering to improve patient care.

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button